Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Astrogliosis as a therapeutic target for neurodegenerative diseases.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.
Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients.
Induction and molecular signature of pathogenic T(H)17 cells.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Dickkopf-3, a tissue-derived modulator of local T-cell responses.
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Optic neuritis combined with hepatitis B and neurosyphilis.
Childhood obesity is a risk factor for multiple sclerosis.
Vitamin D immunomodulatory potential in multiple sclerosis.
Fertility treatment in spinal cord injury and other neurologic disease.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Magnetization transfer from inhomogeneously broadened lines (ihMT): Improved imaging strategy for spinal cord applications.
Time to first relapse as an endpoint in multiple sclerosis clinical trials.
Personalized medicine in multiple sclerosis: hope or reality?
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.

Pages